Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker is gaining ground on its ...

Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...

The Historical Society is reviewing the prints, which for some time had been stored at a San Francisco arthouse, and will develop a plan to exhibit the images, State Historical Society spokeswoman ...

A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...

Let's check out this ultimate pharma stock to buy now. Both drugs are based on the same molecule -- tirzepatide -- but Mounjaro is approved for type 2 diabetes, and Zepbound is approved for weight ...

I'm talking about Eli Lilly (NYSE: LLY), maker of Mounjaro and Zepbound. Both drugs are based on the same molecule — tirzepatide — but Mounjaro is approved for type 2 diabetes, and Zepbound is ...

Celebrities who have taken semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have experienced both health benefits and difficulties on the trendy drugs. GLP-1 drugs, once ...

Copyright 2024 The Associated Press. All Rights Reserved. FILE - Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home, March 1, 2024, in ...

Learn how to get Mounjaro, a prescription medication used to treat diabetes and weight loss in eligible people. Here’s what to know about whether you might qualify, how much it costs ...